BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26018234)

  • 1. Mesenchymal stem cell therapy for inflammatory bowel diseases: promise and challenge.
    Ke C; Biao H; Qianqian L; Yunwei S; Xiaohua J
    Curr Stem Cell Res Ther; 2015; 10(6):499-508. PubMed ID: 26018234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
    Adak S; Mukherjee S; Sen D
    Curr Stem Cell Res Ther; 2017; 12(8):644-657. PubMed ID: 28914206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting improves MSC treatment of inflammatory bowel disease.
    Ko IK; Kim BG; Awadallah A; Mikulan J; Lin P; Letterio JJ; Dennis JE
    Mol Ther; 2010 Jul; 18(7):1365-72. PubMed ID: 20389289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells and chronic inflammatory bowel disease.
    Algeri M; Conforti A; Pitisci A; Starc N; Tomao L; Bernardo ME; Locatelli F
    Immunol Lett; 2015 Dec; 168(2):191-200. PubMed ID: 26170204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Exposition of Mesenchymal Stem Cell for Inflammatory Bowel Disease and Its Associated Colorectal Cancer.
    Kang J; Zhang L; Luo X; Ma X; Wang G; Yang Y; Yan Y; Qian H; Zhang X; Xu W; Mao F
    Biomed Res Int; 2018; 2018():9652817. PubMed ID: 30687760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases.
    Markovic BS; Kanjevac T; Harrell CR; Gazdic M; Fellabaum C; Arsenijevic N; Volarevic V
    Stem Cell Rev Rep; 2018 Apr; 14(2):153-165. PubMed ID: 29177796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases.
    Grégoire C; Lechanteur C; Briquet A; Baudoux É; Baron F; Louis E; Beguin Y
    Aliment Pharmacol Ther; 2017 Jan; 45(2):205-221. PubMed ID: 27878827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy.
    Saadh MJ; Mikhailova MV; Rasoolzadegan S; Falaki M; Akhavanfar R; Gonzáles JLA; Rigi A; Kiasari BA
    Eur J Med Res; 2023 Jan; 28(1):47. PubMed ID: 36707899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of mesenchymal stem cells as a limiting factor in their clinical application to inflammatory bowel disease in dogs and cats.
    Teshima T
    Vet J; 2024 Apr; 304():106090. PubMed ID: 38417670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease.
    Chinnadurai R; Ng S; Velu V; Galipeau J
    World J Gastroenterol; 2015 Apr; 21(16):4779-87. PubMed ID: 25944991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Mesenchymal Stem Cells on the Gut Microbiota and Microbiota Associated Functions in Inflammatory Bowel Disease: A Systematic Review of Preclinical Evidence on Animal Models.
    Liu A; Li C; Wang C; Liang X; Zhang X
    Curr Stem Cell Res Ther; 2024; 19(7):981-992. PubMed ID: 37817517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.
    Zhang X; Wang S; Ding X; Guo J; Tian Z
    Scand J Immunol; 2020 Sep; 92(3):e12897. PubMed ID: 32443180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model.
    Soontararak S; Chow L; Johnson V; Coy J; Wheat W; Regan D; Dow S
    Stem Cells Transl Med; 2018 Jun; 7(6):456-467. PubMed ID: 29635868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?
    Griffin MD; Elliman SJ; Cahill E; English K; Ceredig R; Ritter T
    Stem Cells; 2013 Oct; 31(10):2033-41. PubMed ID: 23766124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell therapy for inflammatory bowel disease.
    Nagaishi K; Arimura Y; Fujimiya M
    J Gastroenterol; 2015 Mar; 50(3):280-6. PubMed ID: 25618180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.
    Ko JZ; Johnson S; Dave M
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells.
    Huldani H; Margiana R; Ahmad F; Opulencia MJC; Ansari MJ; Bokov DO; Abdullaeva NN; Siahmansouri H
    Int Immunopharmacol; 2022 Jun; 107():108698. PubMed ID: 35306284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications Following Stem Cell Therapy in Inflammatory Bowel Disease.
    Wei H; Liu X; Ouyang C; Zhang J; Chen S; Lu F; Chen L
    Curr Stem Cell Res Ther; 2017; 12(6):471-475. PubMed ID: 28302045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell therapies for IBD: what works?
    Ricart E; Jauregui-Amezaga A; Ordás I; Pinó S; Ramírez AM; Panés J
    Curr Drug Targets; 2013 Nov; 14(12):1453-9. PubMed ID: 24160439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.